These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 25298354)

  • 21. Renal Denervation for the Treatment of Hypertension: Making a New Start, Getting It Right.
    Weber MA; Kirtane A; Mauri L; Townsend RR; Kandzari DE; Leon MB
    J Clin Hypertens (Greenwich); 2015 Oct; 17(10):743-50. PubMed ID: 25973584
    [No Abstract]   [Full Text] [Related]  

  • 22. [Questionable efficacy of renal denervation].
    Mariampillai JE; Fadl Elmula FE; Hoffmann P; Sørensen H; Høieggen A; Kjeldsen SE
    Tidsskr Nor Laegeforen; 2014 Sep; 134(17):1643-4. PubMed ID: 25223668
    [No Abstract]   [Full Text] [Related]  

  • 23. [Catheter renal denervation in treatment of resistant hypertension: reality or fiction?].
    Táborský M
    Vnitr Lek; 2014 Apr; 60(4):380-8. PubMed ID: 24986002
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The author replies:
    Luft FC
    Kidney Int; 2014 Nov; 86(5):1060-1. PubMed ID: 25360503
    [No Abstract]   [Full Text] [Related]  

  • 25. Reflections on renal denervation.
    Demaria AN
    J Am Coll Cardiol; 2014 Apr; 63(14):1452-3. PubMed ID: 24721320
    [No Abstract]   [Full Text] [Related]  

  • 26. Current problems in cardiology. Foreword.
    Rahimtoola SH
    Curr Probl Cardiol; 2014 Feb; 39(2):33. PubMed ID: 24412002
    [No Abstract]   [Full Text] [Related]  

  • 27. [Interventional renal sympathetic denervation - a new approach for patients with resistant hypertension].
    Mahfoud F; Böhm M
    Dtsch Med Wochenschr; 2010 Dec; 135(48):2422-5. PubMed ID: 21108158
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ambulatory blood pressure changes after renal sympathetic denervation in patients with resistant hypertension.
    Mahfoud F; Ukena C; Schmieder RE; Cremers B; Rump LC; Vonend O; Weil J; Schmidt M; Hoppe UC; Zeller T; Bauer A; Ott C; Blessing E; Sobotka PA; Krum H; Schlaich M; Esler M; Böhm M
    Circulation; 2013 Jul; 128(2):132-40. PubMed ID: 23780578
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SYMPLICITY HTN-3: failure at 6 months, success at 3 years?
    Fanelli E; Persu A
    Lancet; 2022 Oct; 400(10361):1382-1383. PubMed ID: 36130611
    [No Abstract]   [Full Text] [Related]  

  • 30. [Renal denervation: ready for prime time?].
    Nähle CP; Schild H; Wilhelm K
    Dtsch Med Wochenschr; 2013 Oct; 138(43):2212-8. PubMed ID: 24132535
    [No Abstract]   [Full Text] [Related]  

  • 31. Prevalence of resistant hypertension and eligibility for catheter-based renal denervation in hypertensive outpatients.
    Hayek SS; Abdou MH; Demoss BD; Legaspi JM; Veledar E; Deka A; Krishnan SK; Wilmot KA; Patel AD; Kumar VR; Devireddy CM
    Am J Hypertens; 2013 Dec; 26(12):1452-8. PubMed ID: 23934709
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Renal sympathetic nerve ablation for the management of resistant hypertension: an update.
    Thorp AA; Larsen RN; Schlaich MP
    Curr Opin Nephrol Hypertens; 2013 Nov; 22(6):607-14. PubMed ID: 24100214
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transcatheter renal sympathetic ablation for resistant hypertension: in vivo insights in humans from optical coherence tomography.
    Ierna S; Biondi-Zoccai G; Bachis C; Occhipinti M; Di Vito L; Ricciardi A; Pappone C; Prati F
    Int J Cardiol; 2013 May; 165(2):e35-7. PubMed ID: 23164587
    [No Abstract]   [Full Text] [Related]  

  • 34. Effectiveness of renal denervation to lower blood pressure questioned. Doctors struggle to explain why the procedure lowers high blood pressure more effectively in some patients than in others.
    Duke Med Health News; 2013 Sep; 19(9):4-5. PubMed ID: 24611189
    [No Abstract]   [Full Text] [Related]  

  • 35. Removing the hype from hypertension.
    Shun-Shin MJ; Howard JP; Francis DP
    BMJ; 2014 Mar; 348():g1937. PubMed ID: 24603957
    [No Abstract]   [Full Text] [Related]  

  • 36. Eligibility for renal denervation in patients with resistant hypertension: when enthusiasm meets reality in real-life patients.
    Savard S; Frank M; Bobrie G; Plouin PF; Sapoval M; Azizi M
    J Am Coll Cardiol; 2012 Dec; 60(23):2422-4. PubMed ID: 23141491
    [No Abstract]   [Full Text] [Related]  

  • 37. Sympathetic renal denervation: hypertension beyond SYMPLICITY.
    Barbash IM; Waksman R
    Cardiovasc Revasc Med; 2013; 14(4):229-35. PubMed ID: 23928314
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment resistant hypertension and renal sympathetic denervation: drug adherence and the consolidation of blood pressure lowering effects.
    Kjeldsen SE; Os I; Mahfoud F
    EuroIntervention; 2013 May; 9 Suppl R():R7-9. PubMed ID: 23732159
    [No Abstract]   [Full Text] [Related]  

  • 39. Cardiorespiratory response to exercise after renal sympathetic denervation in patients with resistant hypertension.
    Ukena C; Mahfoud F; Kindermann I; Barth C; Lenski M; Kindermann M; Brandt MC; Hoppe UC; Krum H; Esler M; Sobotka PA; Böhm M
    J Am Coll Cardiol; 2011 Sep; 58(11):1176-82. PubMed ID: 21884958
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Orthostatic function after renal sympathetic denervation in patients with resistant hypertension.
    Lenski M; Mahfoud F; Razouk A; Ukena C; Lenski D; Barth C; Linz D; Laufs U; Kindermann I; Böhm M
    Int J Cardiol; 2013 Nov; 169(6):418-24. PubMed ID: 24157238
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.